Prognosis
FDA Approves Ebola Vaccine With 100% Effectiveness
- Merck developed vaccine after Canadian research work
- Vaccine was highly effective in earlier testing in outbreak
An Ebola survivor sits in her bedroom in Beni, north eastern Democratic Republic of the Congo on Sept. 17.
Photographer: John Wessels/AFP via Getty ImagesThis article is for subscribers only.
Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter
U.S. regulators have approved a vaccine to protect against the deadly Ebola virus, a crucial step in the battle against an infection that’s considered one of the world’s deadliest killers.